General Information
Novo Nordisk DM SWITCH 2 3998
A randomised, double blind, cross-over trial comparing the safety and efficacy of insulin degludec and insulin glargine, both in combination with metformin in subjects with type 2 diabetes
| Protocol | NN1250-3998 |
|---|---|
| Identifier | NN1250-3998 Site Number 359 V#1157252 |
| UID | a7cd9051-7eaa-4305-8c5a-c2a809331891 |
| Status | Done - Archived |
| Phase | 3b |
| Category | Diabetes Type 2 |
| Launch Year | 2014 |
| NCT Number | - |
| Created | 2013-09-10 10:51 |
| Last Updated | 2013-09-10 10:51 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2014-09-07 | No |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2014-02-17 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2016-02-18 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Moon, Mia | MMoon | No |
| Recruiter | - | No | |
| Coordinator | Pereira, Cynthia | CPereira | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Novo Nordisk |
|---|---|
| Division | Novo Nordisk |
| Team | Novo Nordisk |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
